Gain Therapeutics, Inc. (GANX)
NASDAQ·Healthcare·Biotechnology
$1.87
-4.36%
Mkt Cap $82.37M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (5 analysts)
$8.33
Range $7.00 – $10.00
Implied Upside
+346.6%
Consensus $8.33 vs current $1.87
NASDAQ·Healthcare·Biotechnology
$1.87
-4.36%
Mkt Cap $82.37M
Buy
1
Hold
0
Sell
0
Price Target (5 analysts)
$8.33
Range $7.00 – $10.00
+346.6%
Consensus $8.33 vs current $1.87